507 related articles for article (PubMed ID: 22665815)
1. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
Li P; McElligott S; Bergquist H; Schwartz JS; Doshi JA
Ann Intern Med; 2012 Jun; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
[TBL] [Abstract][Full Text] [Related]
2. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products.
Zhang Y; Lave JR; Donohue JM; Fischer MA; Chernew ME; Newhouse JP
Med Care; 2010 May; 48(5):409-17. PubMed ID: 20393360
[TBL] [Abstract][Full Text] [Related]
3. The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.
Baik SH; Rollman BL; Reynolds CF; Lave JR; Smith KJ; Zhang Y
J Ment Health Policy Econ; 2012 Sep; 15(3):105-18. PubMed ID: 23001279
[TBL] [Abstract][Full Text] [Related]
4. Transition probabilities and predictors of adherence in a California Medicaid population using antihypertensive and lipid-lowering medications.
Nichol MB; Knight TK; Wu J; Tang SS; Cherry SB; Benner JS; Hussein M
Value Health; 2009 Jun; 12(4):544-50. PubMed ID: 19138308
[TBL] [Abstract][Full Text] [Related]
5. Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression.
Zhang Y; Baik SH; Zhou L; Reynolds CF; Lave JR
Arch Gen Psychiatry; 2012 Jul; 69(7):672-9. PubMed ID: 22752233
[TBL] [Abstract][Full Text] [Related]
6. Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
Conwell LJ; Esposito D; Garavaglia S; Meadows ES; Colby M; Herrera V; Goldfarb S; Ball D; Marciniak M
Am J Geriatr Pharmacother; 2011 Aug; 9(4):241-9. PubMed ID: 21616722
[TBL] [Abstract][Full Text] [Related]
7. Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan.
Nair KV; Frech-Tamas F; Jan S; Wolfe P; Allen RR; Saseen JJ
J Health Care Finance; 2011; 38(2):38-53. PubMed ID: 22372031
[TBL] [Abstract][Full Text] [Related]
8. The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs*.
Chapman RH; Ferrufino CP; Kowal SL; Classi P; Roberts CS
Int J Clin Pract; 2010 Jan; 64(2):169-81. PubMed ID: 20089007
[TBL] [Abstract][Full Text] [Related]
9. Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase.
Park H; Rascati KL; Lawson KA; Barner JC; Richards KM; Malone DC
J Manag Care Spec Pharm; 2014 Aug; 20(8):862-76. PubMed ID: 25062080
[TBL] [Abstract][Full Text] [Related]
10. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
[TBL] [Abstract][Full Text] [Related]
11. Out-of-plan medication in Medicare Part D.
Roberto PN; Stuart B
Am J Manag Care; 2014 Sep; 20(9):743-8. PubMed ID: 25365749
[TBL] [Abstract][Full Text] [Related]
12. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
Goedken AM; Urmie JM; Farris KB; Doucette WR
Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
[TBL] [Abstract][Full Text] [Related]
13. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy.
Benner JS; Chapman RH; Petrilla AA; Tang SS; Rosenberg N; Schwartz JS
Am J Health Syst Pharm; 2009 Aug; 66(16):1471-7. PubMed ID: 19667004
[TBL] [Abstract][Full Text] [Related]
14. Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence.
Amin K; Farley JF; Maciejewski ML; Domino ME
J Manag Care Spec Pharm; 2017 Mar; 23(3):337-345. PubMed ID: 28230447
[TBL] [Abstract][Full Text] [Related]
15. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
Blumberg DM; Prager AJ; Liebmann JM
JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
[TBL] [Abstract][Full Text] [Related]
16. Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare Part D.
Frankenfield DL; Weinhandl ED; Powers CA; Howell BL; Herzog CA; St Peter WL
Am J Kidney Dis; 2012 May; 59(5):670-81. PubMed ID: 22206743
[TBL] [Abstract][Full Text] [Related]
17. Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer.
Adams AS; Madden JM; Zhang F; Lu CY; Ross-Degnan D; Lee A; Soumerai SB; Gilden D; Chawla N; Griggs JJ
Value Health; 2017 Dec; 20(10):1345-1354. PubMed ID: 29241894
[TBL] [Abstract][Full Text] [Related]
18. Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006.
Li P; Schwartz JS; Doshi JA
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27836822
[TBL] [Abstract][Full Text] [Related]
19. Effects of Medicare Part D coverage gap on medication adherence.
Zhang Y; Baik SH; Lave JR
Am J Manag Care; 2013 Jun; 19(6):e214-24. PubMed ID: 23844750
[TBL] [Abstract][Full Text] [Related]
20. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia.
Doshi JA; Li P; Desai S; Marcus SC
J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
